跳至主要内容
临床试验/NCT01149577
NCT01149577已完成4 期

Effect of Olanzapine on Sleep Electroencephalogram (EEG) in Schizophrenia Patients

Central Institute of Psychiatry, Ranchi, India1 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2007年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
25
试验地点
1
主要终点
Sleep EEG

研究概览

简要总结

Acute and sub-chronic administration of olanzapine has shown a favourable effect on the sleep disturbances in previously medicated schizophrenia patients with predominantly negative symptoms. The present study will be carried out to clarify the effect of olanzapine on polysomnographic profiles of schizophrenia patients in an acute phase of illness after controlling for the drug effects.

详细描述

Twenty schizophrenia patients (11 drug naïve and 9 drug free) will be studied over a period of six weeks of olanzapine treatment. Patients will be assessed at the baseline on BPRS, PANSS, CDSS and UKU side effect rating scales and a baseline 40 channels polysomnography will be done. After the initial assessment, patients will put on olanzapine treatment, in flexible dosages based on clinical response, for a period of six weeks when a final assessment on clinical rating scales and polysomnography will be done. The sleep data will be scored manually for staging based on Rechtschaffen and Kales criteria.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Basic Science
盲法
None

入排标准

年龄范围
18 Years 至 45 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Male patients fulfilling International Classification of Diseases-10 Diagnostic Criteria for Research for schizophrenia
  • Aged 18-50 Yrs
  • Drug naïve or drug free (not receiving any psychotropic medication for the past 4 months)

排除标准

  • Any comorbid psychiatric illness
  • Significant medical or neurological illness
  • History of significant head injury, epilepsy
  • Substance use in the past 4 months excluding nicotine and caffeine
  • Presence of a primary sleep disorder

研究组 & 干预措施

Schizophrenia patients

Experimental

The study population of 25 schizophrenia patients constituted the active arm of the study.

干预措施: Olanzapine (Drug)

结局指标

主要结局

Sleep EEG

时间窗: 06 weeks

Changes in Sleep EEG parameters like Total sleep time, total sleep period, sleep efficiency, sleep latency, stage shifts, stage 1 shifts, stage 1 parameters, stage 2 parameters, stage 3 parameters, stage 4 parameters, rapid eye movement (REM) parameters.

次要结局

  • Psychopathology(06 weeks)

研究者

发起方
Central Institute of Psychiatry, Ranchi, India
申办方类型
Other

研究点 (1)

Loading locations...

相似试验